A GWAS sequence variant for platelet volume marks an alternative DNM3 promoter in megakaryocytes near a MEIS1 binding site

Autor: Nürnberg ST, Rendon A, Smethurst PA, Paul DS, Voss K, Thon JN, Lloyd Jones H, Sambrook JG, Tijssen MR, Gieger C, Radhakrishnan A, Cvejic A, Tang W, Porcu E, Pistis G, Serbanovic Canic J, Elling U, Goodall AH, Labrune Y, Lopez LM, Mägi R, Meacham S, Okada Y, Sorice R, Teumer A, Zhang W, Ramirez Solis R, Bis JC, Ellinghaus D, Gögele M, Hottenga JJ, Langenberg C, Kovacs P, F. P, Shin SY, Esko T, Hartiala J, Kanoni S, Murgia F, Parsa A, Stephens J, van der Harst P, van der Schoot C, Allayee H, Attwood A, Balkau B, Bastardot F, Basu S, Baumeister SE, Biino G, Bomba L, Bonnefond A, Cambien F, Chambers JC, Cucca F, Davies G, de Geus EJ, de Boer RA, Döring A, Elliott P, Erdmann J, Feng W, Evans DM, Falchi M, Folsom AR, Frazer IH, Gibson QD, Glazer NL, Hammond C, Hartikainen AL, Heckbert SR, Hengstenberg C, Hersch M, Illig T, Loos RJ, Jolley J, Khaw KT, Kühnel B, Kyrtsonis MC, Lagou V, Lumley T, Mangino M, Maschio A, Mateo Leach I, McKnight B, Memari Y, Mitchell BD, Montgomery GW, Nöthlings U, Nakamura Y, Nauck M, Navis G, Nolte IM, Porteous DJ, Pouta A, Pramstaller PP, Pullat J, Ring SM, Rotter JI, Ruggiero D, Ruokonen A, Sala C, Samani NJ, Sambrook J, Schlessinger D, Schreiber S, Schunkert H, Scott J, Smith NL, Snieder H, Starr JM, Stumvoll M, Takahashi A, Taylor K, Tenesa A, Thein SL, Tönjes A, Uda M, Ulivi S, Wichmann HE, Yang TP, van Veldhuisen DJ, Visscher PM, Völker U, Wiggins KL, Willemsen G, Zhao JH, Zitting P, Bradley JR, Dedoussis GV, Hazen SL, Metspalu A, Pirastu M, Shuldiner AR, van Pelt L, Zwaginga JJ, Boomsma DI, Deary IJ, Franke A, Froguel P, Ganesh SK, Jarvelin MR, Martin NG, Meisinger C, Psaty BM, Spector TD, Wareham NJ, Akkerman JW, Ciullo M, Deloukas P, Greinacher A, Jupe S, Kamatani N, Khadake J, Kooner JS, Penninger J, Prokopenko I, Stemple D, Toniolo D, Wernisch L, Sanna S, Hicks AA, Ferreira MA, Italiano JE Jr, Gottgens B, Soranzo N, Ouwehand WH, PIRASTU, Nicola, D'ADAMO, ADAMO PIO, GASPARINI, PAOLO

Publikováno v: Blood 120 (2012): 4859–4868. doi:10.1182/blood-2012-01-401893
info:cnr-pdr/source/autori:Nurnberg ST, Rendon A, Smethurst PA, Paul DS, Voss K, Thon JN, Lloyd-Jones H, Sambrook JG, Tijssen MR; HaemGen Consortium, Italiano JE Jr, Deloukas P, Gottgens B, Soranzo N, Ouwehand WH./titolo:A GWAS sequence variant for platelet volume marks an alternative DNM3 promoter in megakaryocytes near a MEIS1 binding site./doi:10.1182%2Fblood-2012-01-401893/rivista:Blood/anno:2012/pagina_da:4859/pagina_a:4868/intervallo_pagine:4859–4868/volume:120
Nürnberg, S T, Rendon, A, Smethurst, P A, Paul, D S, Voss, K, Thon, J N, Lloyd-Jones, H, Sambrook, J G, Tijssen, M R, Hottenga, J J, de Geus, E J C, Willemsen, G, Boomsma, D I, Italiano Jr, J E, Deloukas, P, Gottgens, B, Soranzo, N & Ouwehand, W H 2012, ' A GWAS sequence variant for platelet volume marks an alternative DNM3 promoter in megakaryocytes near a MEIS1 binding site ', Blood, vol. 120, no. 24, pp. 4859-4868 . https://doi.org/10.1182/blood-2012-01-401893
Blood, 120(24), 4859-4868. American Society of Hematology
Nürnberg, S T, Rendon, A, Smethurst, P A, Paul, D S, Voss, K, Thon, J N, Lloyd-Jones, H, Sambrook, J G, Tijssen, M R, Italiano, J E, Deloukas, P, Gottgens, B, Soranzo, N, Ouwehand, W H & Pirastu, N 2012, ' A GWAS sequence variant for platelet volume marks an alternative DNM3 promoter in megakaryocytes near a MEIS1 binding site ', Blood, vol. 120, no. 24, pp. 4859-68 . https://doi.org/10.1182/blood-2012-01-401893

We recently identified 68 genomic loci where common sequence variants are associated with platelet count and volume. Platelets are formed in the bone marrow by megakaryocytes, which are derived from hematopoietic stem cells by a process mainly contro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae2e64f26a5f52ff78d19ed098857b3b
https://hdl.handle.net/11368/2649910

Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction

Autor: Kerkhoffs, JLH, Putten, Wim, Novotny, Viera M.J., te Boekhorst, Peter, Schipperus, MR, Zwaginga, JJ, van Pampus, LCM, Greef, Georgine, Luten, Marleen, Huijgens, PC, Brand, A, Rhenen, Dick

Publikováno v: British Journal of Haematology, 150(2), 209-217. Wiley-Blackwell Publishing Ltd

P>Pathogen reduction (PR) of platelet products increases costs and available clinical studies are equivocal with respect to clinical and haemostatic effectiveness. We conducted a multicentre, open-label, randomized, non-inferiority trial comparing th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::666e56a381fc966eade16d1b1ef7b63b
https://pure.eur.nl/en/publications/331178e0-82ac-4de7-a428-ba90a76d114f

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.